Clinical Research at Minnesota Urology
Research Offices
6025 Lake Road
Woodbury, MN 55125

Clinical Research Coordinator: 651-999-7033
Clinical Research Manager: 651-999-7032

Minnesota Urology is committed to providing the highest quality urologic care, and this includes being able to provide “cutting edge” therapies and treatments for its patients by conducting clinical trials. While most private urology practices do not conduct research, Minnesota Urology has a large core group of physicians that actively engage in clinical research and are fully supported by full-time, experienced research staff who are certified in clinical research.

Minnesota Urology conducts a variety of different types of clinical studies, including observational patient registries/ observational studies as well as randomized, interventional clinical trials. Clinical trials are designed to study the safety and effectiveness of new products or interventions (e.g., drugs, biologics, devices, surgical techniques) in different phases.

About Clinical Research. At Minnesota Urology, we conduct a variety of different types of clinical studies, from observational studies to large, randomized, controlled interventional clinical trials. We conduct Phase II and Phase III clinical trials that are especially important for getting new treatment options approved for clinical care. Phase II trials are initial studies that are conducted to evaluate the safety and effectiveness of a new treatment, therapy or technique with patients that the intervention is intended to treat. Phase III trials are conducted with a much larger group of patients across many more clinical sites to further study its safety and effectiveness. A Phase III clinical trial is often referred to as a “pivotal trial” when the intended purpose of the clinical trial is to obtain FDA approval so that it can be marketed and sold within the U.S. Phase IV clinical studies are additional studies that are conducted once the new product is approved to be on the market. Post-market studies may be required by the FDA or companies may just decide to do them to get different kinds data that is also helpful for marketing or reimbursement purposes. In addition to clinical trials, Minnesota Urology also conducts biomarker and genomic studies to validate tests that may improve the ability to detect cancer earlier, help predict the aggressiveness of the cancer or response to treatment in individual patients.

Current Clinical Studies. Minnesota Urology is currently conducting clinical research for a number of different urologic conditions and cancers. Some of these studies are still open for enrollment. If you are interested in learning more about our clinical research program or current studies, please contract a member of our research staff.

We are currently enrolling new patient subjects for the following studies:

  Study Title Click on link below for more information about study
Bladder Cancer The Efficacy of the Bladder EpiCheck for Detection of Recurrent Urothelial Cell Carcinoma: A Multicenter, Prospective Blinded Pivotal Study

Prostate Cancer

Observational Cohort Study of Patients with Castration-Resistant Prostate Cancer (CRPC) in the United States (TRUMPET)

Urethral Stricture

Re-establishing Flow Via Drug Coated Balloon for the Treatment of Urethral Stricture Disease (ROBUST II)

Urinary Incontinence Due to Neurogenic bladder

A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis (CONTENT 1)
Urinary Incontinence/Urgency

Axonics Sacral Neuromodulation System for Urinary Urgency Incontinence Treatment (ARTISAN-SNM)